JP2023537115A5 - - Google Patents
Info
- Publication number
- JP2023537115A5 JP2023537115A5 JP2023509614A JP2023509614A JP2023537115A5 JP 2023537115 A5 JP2023537115 A5 JP 2023537115A5 JP 2023509614 A JP2023509614 A JP 2023509614A JP 2023509614 A JP2023509614 A JP 2023509614A JP 2023537115 A5 JP2023537115 A5 JP 2023537115A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- binds
- human
- protein
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063065085P | 2020-08-13 | 2020-08-13 | |
| US63/065,085 | 2020-08-13 | ||
| PCT/EP2021/072020 WO2022033978A2 (en) | 2020-08-13 | 2021-08-06 | Cancer treatment methods using anti-cd73 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023537115A JP2023537115A (ja) | 2023-08-30 |
| JP2023537115A5 true JP2023537115A5 (https=) | 2024-08-08 |
Family
ID=77595505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509614A Pending JP2023537115A (ja) | 2020-08-13 | 2021-08-06 | 抗ｃｄ７３抗体を使用する癌処置方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240270865A1 (https=) |
| EP (1) | EP4196500A2 (https=) |
| JP (1) | JP2023537115A (https=) |
| KR (1) | KR20230050378A (https=) |
| CN (1) | CN116194483A (https=) |
| WO (1) | WO2022033978A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021012769A (es) | 2019-04-23 | 2021-11-18 | Innate Pharma | Anticuerpos bloqueadores cd73. |
| WO2025162964A1 (en) | 2024-01-30 | 2025-08-07 | Institut National de la Santé et de la Recherche Médicale | Methods for the treatment of endometriosis |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US7923029B2 (en) | 2002-04-11 | 2011-04-12 | Medimmune Llc | Spray freeze dry of compositions for pulmonary administration |
| WO2003087327A2 (en) | 2002-04-11 | 2003-10-23 | Medimmune Vaccines, Inc. | Preservation of bioactive materials by freeze dried foam |
| WO2003087335A2 (en) | 2002-04-11 | 2003-10-23 | Medimmune Vaccines, Inc. | Preservation of bioactive materials by spray drying |
| US20040042972A1 (en) | 2002-04-11 | 2004-03-04 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for intranasal administration |
| ATE483472T1 (de) | 2002-05-30 | 2010-10-15 | Macrogenics Inc | Cd16a bindungsproteine und verwendung zur behandlung von immunkrankheiten |
| CN1745170A (zh) | 2002-12-17 | 2006-03-08 | 米迪缪尼疫苗股份有限公司 | 生物活性材料的高压喷雾干燥 |
| US8961967B2 (en) | 2009-11-30 | 2015-02-24 | Janssen Biotech, Inc. | Antibody Fc mutants with ablated effector functions |
| AR083847A1 (es) | 2010-11-15 | 2013-03-27 | Novartis Ag | Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40 |
| ES2773710T3 (es) | 2012-10-11 | 2020-07-14 | Daiichi Sankyo Co Ltd | Enlazadores para conjugados de anticuerpo - fármaco |
| WO2016131950A1 (en) | 2015-02-20 | 2016-08-25 | Innate Pharma | Cd73 blockade |
| EP3204417B1 (en) | 2014-10-10 | 2020-07-22 | Innate Pharma | Cd73 blockade |
| CA3045376C (en) | 2017-01-24 | 2022-08-30 | I-Mab | Anti-cd73 antibodies and uses thereof |
| MY204117A (en) | 2017-06-22 | 2024-08-08 | Novartis Ag | Antibody molecules to cd73 and uses thereof |
| EP3642240A1 (en) * | 2017-06-22 | 2020-04-29 | Novartis AG | Antibody molecules to cd73 and uses thereof |
| CA3074208C (en) | 2017-08-31 | 2023-10-03 | Daiichi Sankyo Company, Limited | Novel method for producing antibody-drug conjugate |
| WO2019173692A2 (en) * | 2018-03-09 | 2019-09-12 | Agenus Inc. | Anti-cd73 antibodies and methods of use thereof |
| WO2020041404A1 (en) * | 2018-08-23 | 2020-02-27 | Macrogenics, Inc. | Pd-l1-binding molecules and use of the same for the treatment of disease |
| MX2021012769A (es) * | 2019-04-23 | 2021-11-18 | Innate Pharma | Anticuerpos bloqueadores cd73. |
-
2021
- 2021-08-06 KR KR1020237007954A patent/KR20230050378A/ko active Pending
- 2021-08-06 WO PCT/EP2021/072020 patent/WO2022033978A2/en not_active Ceased
- 2021-08-06 US US18/020,955 patent/US20240270865A1/en active Pending
- 2021-08-06 CN CN202180055645.3A patent/CN116194483A/zh active Pending
- 2021-08-06 EP EP21763253.8A patent/EP4196500A2/en active Pending
- 2021-08-06 JP JP2023509614A patent/JP2023537115A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9522956B2 (en) | Combination therapy using anti-EGFR and anti-HER2 antibodies | |
| AU2016263808B2 (en) | Trispecific binding proteins and methods of use | |
| US20040052785A1 (en) | Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors | |
| JPH08504172A (ja) | 抗−ｅｒｂＢ−２モノクロナール抗体の組み合わせ物及び使用方法 | |
| JP2004501101A (ja) | Ｈｅｒ２に対する抗体およびインターロイキン−２の組み合わせの使用による癌の処置 | |
| US20120294873A1 (en) | ANTI-EpCAM IMMUNOGLOBULINS | |
| EP1282440A1 (en) | Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumor agents | |
| JP2023544143A5 (https=) | ||
| WO2023061472A1 (zh) | 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途 | |
| JP2022513421A5 (https=) | ||
| JP2023537115A5 (https=) | ||
| JP2022541591A5 (https=) | ||
| JPS63238023A (ja) | 抗腫瘍イムノトキシン及び腫瘍壊死因子を含んで成る医薬 | |
| CN118373896B (zh) | 抗pd-1抗体与il-2突变体的双功能融合蛋白 | |
| WO2025103379A1 (zh) | 抗b7h3抗体-药物偶联物治疗癌症的方法 | |
| JP2022502434A5 (https=) | ||
| KR101746152B1 (ko) | ＥｒｂＢ3에 특이적으로 결합하는 항체 및 그의 용도 | |
| JP2023545983A5 (https=) | ||
| JP2005525317A (ja) | Ｈｅｒ２レセプタータンパク質の過剰発現によって特徴づけられる癌のための組み合わせｉｌ−２／抗ｈｅｒ２抗体治療 | |
| CN121622921A (zh) | Her2 adc药物组合物及其用途 | |
| WO2025252203A1 (zh) | 抗Nectin-4抗体药物偶联物治疗肿瘤的用途 | |
| WO2025201522A1 (zh) | 抗Nectin-4抗体药物偶联物治疗肿瘤 | |
| CN113993544A (zh) | 用于治疗egfr高表达的癌症的多变剂量方法 | |
| JPH06509541A (ja) | 免疫複合体 | |
| EP1465661A1 (en) | Cancer treatment |